Release Date: 20/11/14 15:16 Summary: Results of Annual General Meeting Price Sensitive: No Download Document 49.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%